RPS 2006 - Hybrid and molecular imaging in oncology: clinical and translational studies

Ga-68-FAPI PET/CT in Malignant Mesothelioma: Prospective Single-Center Observational Trial

Diagnostic accuracy and molecular characterization of endometrial cancer using fully hybrid [18F]FDG PET/MRI

Prognosticating axillary lymph node metastasis in breast cancer through integrated photoacoustic imaging, ultrasound, and clinical parameters

Implmentation of Diffusion Weighted Imaging for whole body staging of lymphoma patients

In pursuit of an appropriate use criteria for the use of 18-F FES PET CT in the management of ER positive breast cancer : work in progress

[1-11C]acetate PET/CT distinguishes aggressive cribriform Gleason score 7 prostate cancer and is mechanistically informed by spatial metabolomics

The Role of [ 68 Ga]Ga FAPi PET/CT in Staging and Restaging in Breast Cancer with Low FDG Uptake

Can 18F-FDG-PET CT Predict Mediastinal Lymph Node Metastases in NSCLC Patients Undergoing Neo-Adjuvant Immuno-Chemotherapy?

Real-Time Monitoring of Intratherapeutic Body Fat Loss during Radioligand Therapy with [177Lu]Lu-PSMA Predicts Survival in Prostate Cancer Patients

Integrated diagnostics for survival prediction in patients with GEP-NET undergoing PRRT

Multi-radiotracer PET/CT for the evaluation of coronary and carotid atherosclerotic plaque vulnerability: A systematic review

Lymphoma Therapy Response Assessment with Low-Dose [18F]FDG Total-Body PET/CT